Jack Jan is an experienced professional in pricing and contracting within the pharmaceutical industry, currently serving as Director of Pricing & Contracting at Eisai US since January 2023. Prior experience includes roles as Director of Strategic Pricing & Reimbursement at Bayer Pharmaceuticals, where responsibilities encompassed evaluating IRA drug pricing reform, overseeing price planning for oncology and cell & gene therapies, and conducting pricing research to enhance patient access to medicines. Earlier positions include Deputy Director of Contract Analysis at Novartis and various leadership roles at Roche Pharmaceuticals, Eisai, and Chemical Bank. Jack's educational background includes studies at Rutgers University and Barringer High School.
This person is not in the org chart
This person is not in any teams
This person is not in any offices